Accession Number: | 0001209191-22-034259 |
Date: | 2022-06-01 |
Issuer: | CYTEK BIOSCIENCES, INC. (CTKB) |
Original Submission Date: |
DION GISELE
C/O CYTEK BIOSCIENCES, INC.
46107 LANDING PARKWAY
FREMONT, CA 94538
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
STOCK OPTION (RIGHT TO BUY) | 9.67 | 2022-06-01 | deemed execution date | A | 25,789 (a) | 2023-06-01 | 2032-06-01 | common stock 25,789 | $9.67 | 25,789 | direct |
ID | footnote |
---|